CIBC Private Wealth Group’s Harmony Biosciences HRMY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $106K | Buy |
3,368
+58
| +2% | +$1.83K | ﹤0.01% | 1355 |
|
|
2025
Q1 | $93.1K | Sell |
3,310
-904
| -21% | -$25.4K | ﹤0.01% | 1387 |
|
|
2024
Q4 | $146K | Buy |
4,214
+1,681
| +66% | +$58K | ﹤0.01% | 1283 |
|
|
2024
Q3 | $101K | Buy |
2,533
+1,033
| +69% | +$41.3K | ﹤0.01% | 1474 |
|
|
2024
Q2 | $48.8K | Buy |
1,500
+82
| +6% | +$2.67K | ﹤0.01% | 1688 |
|
|
2024
Q1 | $46.8K | Buy |
+1,418
| New | +$46.8K | ﹤0.01% | 1710 |
|
|
2022
Q2 | – | Sell |
-11,434
| Closed | -$557K | – | 1243 |
|
|
2022
Q1 | $557K | Sell |
11,434
-48,566
| -81% | -$2.37M | ﹤0.01% | 728 |
|
|
2021
Q4 | $2.56M | Hold |
60,000
| – | – | 0.01% | 488 |
|
|
2021
Q3 | $2.3M | Buy |
60,000
+1,000
| +2% | +$38.3K | 0.01% | 487 |
|
|
2021
Q2 | $1.67M | Buy |
+59,000
| New | +$1.67M | ﹤0.01% | 560 |
|